Involvement of NK cells against tumors and parasites

International Journal of Biological Markers

Volumn 22, Issue 2, 2007, Pages 144-153

  Papazahariadou, M ^a   Athanasiadis, G I ^b   Papadopoulos, E ^a   Symeonidou, I ^a   Hatzistilianou, M ^a   Castellani, Maria Luisa ^c   Bhattacharya, K ^d   Shanmugham, L N ^e   Conti, P ^c   Frydas, S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Private Practice   (Greece)

^c UNIVERSITY OF CHIETI   (Italy)

^d WESTERN INFIRMARY   (United Kingdom)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

IFN ; Innate immunity; Natural killer cell; Parasites; Regulatory cytokines; Tumor

Indexed keywords

GAMMA INTERFERON;

ADAPTIVE IMMUNITY; ARTICLE; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL INTERACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; EOSINOPHIL; EPIMASTIGOTE; FIBROBLAST; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR RECOGNITION; MONOCYTE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; TRYPANOSOMA CRUZI; TRYPANOSOMA LEWISI; TRYPOMASTIGOTE; TUMOR CELL;

EID: 34447315001     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.2051     Document Type: Article

References (95)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
2. Scott P, Trinchieri G. The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 1995; 7: 34-40.
3. Trakatelli C, Frydas S, Hatzistilianou M, et al. Chemokines as markers for parasite-induced inflammation and tumors. Int J Biol Markers 2005; 20: 197-203.
4. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Ann Rev Immunol 1999; 17: 189-220.
5. Lieke T, Steeg C, Grafe SE, Fleischer B, Jacobs T. Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts. Clin Exp Immunol 2006; 145: 357-64.
6. Serviddio G, Carpagnano GE, Rollo T, et al. Evidence of lower oxidative stress in the air spaces of patients with reversible COPD. Int J Immunopathol Pharmacol 2006; 19: 617-28.
7. Passacantando A, Parzanese I, Rascente M, Petrucci C, Minisola G, Tonietti G. Synovial fluid OX40T lymphocytes of patients with rheumatoid arthritis display a Th2/Th0 polarization. Int J Immunopathol Pharmacol 2006; 19: 499-506.
8. Jiang F, Li WP, Kwiecien J, Turnbull J. A study of the purine derivative AIT-082 in G93A SOD1 transgenic mice. Int J Immunopathol Pharmacol 2006; 19: 489-98.
9. Korbel DS, Finney OC, Riley EM. Natural killer cells and innate immunity to protozoan pathogens. Int J Parasitol 2004, 34: 1517-28.
10. Schiavino D, Nucera E, Alonzi C, et al. A clinical trial of oral hyposensitization in systemic allergy to nickel. Int J Immunopathol Pharmacol 2006; 19: 593-600.
11. Manoury B, Caulet-Maugendre S, Guénon I, Lagente V, Boichot E. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Int J Immunopathol Pharmacol 2006; 19: 471-88.
12. Sirolli V, Amoroso L, Pietropaolo M, Grandaliano G, Pertosa G, Bonomini M. Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? Int J Immunopathol Pharmacol 2006; 19: 461-70.
13. Marchisio M, Bertagnolo V, Lanuti P, et al. Nuclear protein kinase C-δ: a possible check-point of cell cycle progression. Int J Immunopathol Pharmacol 2006; 19: 287-92.
14. Di Lorenzo G, Pacor ML, Mansueto P, et al. Relationship between specific serum IgE to Ascaris lumbricoides and onset of respiratory symptoms in Bangladesh immigrants. Int J Immunopathol Pharmacol 2006; 19: 629-38.
15. Hatcher FM, Kuhn RE, Cerrone MC, Burton RC. Increased natural killer cell activity in experimental American trypanosomiasis. J Immunol 1981, 127: 1126-30.
16. Wu P, Miura Y, Hyodoh F, et al. Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients. Int J Immunopathol Pharmacol 2006; 19: 357-68.
17. Avanzini MA, Ricci A, Scaramuzza C, et al. Deficiency of INFγ producing cells in adenoids of children exposed to passive smoke. Int J Immunopathol Pharmacol 2006; 19: 609-16.
18. Duthie MS, Kahn SJ. NK activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection. Int Immunol 2005, 17: 607-13.
19. Caproni M, Giomi B, Melani L, et al. Cellular infiltrate and related cytokines, chemokines, chemokine receptors and adhesion molecules in chronic autoimmune urticaria: comparison between spontaneous and autologous serum skin test induced wheal. Int J Immunopathol Pharmacol 2006; 19: 507-16.
20. Mayilyan KR, Presanis JS, Arnold JN, Sim RB. Discrete MBL-MASP complexes show wide inter-individual variability in concentration: data from UK vs. Armenian populations. Int J Immunopathol Pharmacol 2006; 19: 567-80.
21. Trubiani O, Orsini G, Caputi S, Piattelli A. Adult mesenchymal stem cells in dental research: a new approach for tissue engineering. Int J Immunopathol Pharmacol 2006; 19: 451-60.
22. Ferrini AM, Mannoni V, Aureli P, et al. Melaleuca alternifolia essential oil possesses potent anti-staphylococcal activity extended to strains resistant to antibiotics. Int J Immunopathol Pharmacol 2006; 19: 539-44.
23. Di Pietro R, Fang H, Fields K, et al. Peroxiredoxin genes are not induced in myeloid leukemia cells exposed to ionizing radiation. Int J Immunopathol Pharmacol 2006; 19: 517-24.
24. Lanzilli G, Falchetti R, Cottarelli A, Macchi A, Ungheri D, Fuggetta MP. In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. Int J Immunopathol Pharmacol 2006; 19: 551-60.
25. Burastero SE, Paolucci C, Breda D, Ponti J, Munaro B, Sabbioni E. Chromium (VI)-induced immunotoxicity and intra-cellular accumulation in human primary dendritic cells. Int J Immunopathol Pharmacol 2006; 19: 581-92.
26. Rottenberg M, Cardoni RL, Anderson R, Segura EL, Orn A. Role of T helper/ inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand J Immunol 1988, 28: 573-82.
27. Bei R, Mentuccia D, Trono P, et al. Immunity to extracellular matrix antigens is associated with ultrastructural alterations of the stroma and stratified epithelium basement membrane in the skin of Hashimoto's thyroiditis patients. Int J Immunopathol Pharmacol 2006; 19: 661-74.
28. Santino I, Scazzocchio F, Ciceroni L, Ciarrocchi S, Sessa R, Del Piano M. In vitro susceptibility of isolates of Borrelia burgdorferi s.l. to antimicrobial agents. Int J Immunopathol Pharmacol 2006; 19: 545-50.
29. Barreto M, Villa MP, Corradi M, et al. Non-invasive assessment of airway inflammation in ship-engine workers. Int J Immunopathol Pharmacol 2006; 19: 601-8.
30. De Arruda Hinds LB, Previato LM, Previato JO, Vos Q, Mond JJ, Pecantia LM. Modulation of B-lymphocyte and NK cell activities by glycoinositolphospholipid purified from Trypanosoma cruzi. Infect Immun 1999; 67: 6179-89.
31. Di Renzo M, Pasqui AL, Rubegni P, et al. Inhibition of maturation of human monocyte-derived dendritic cells in a patient with Myobacterium avium infection. Int J Immunopathol Pharmacol 2006; 19: 391-8.
32. Stratta P, Canavese C, Fenoglio R, et al. Dual effect of methylprednisolone pulses on apoptosis of peripheral leukocytes in patients with renal diseases. Int J Immunopathol Pharmacol 2006; 19: 647-60.
33. Chen CG, Yang YL, Cheng HH, et al. Non-lethal Candida albicans cph1/ cph1 efg1/efg1 transcription factor mutant establishing restricted zone of infection in a mouse model of systemic infection. Int J Immunopathol Pharmacol 2006; 19: 561-6.
34. Licata G, Tuttolomondo A, Corrao S, et al. Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. Int J Immunopathol Pharmacol 2006; 19: 639-46.
35. Khan IA, Thomas SY, Moretto MM, et al. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLos Pathog 2006; 2: e49.
36. Castellani ML, Salini V, Frydas S, et al. The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity. Int J Immunopathol Pharmacol 2006; 19: 247-52.
37. Corsaro A, Paludi D, Villa V, et al. Conformation dependen pro-apoptotic activity of the recombinant human prion protein fragment 90-231. Int J Immunopathol Pharmacol 2006; 19: 339-56.
38. Lang S, Picu A, Hofmann T, et al. Cox-inhibitors relieve the immunosuppressive effect of tumor cells and improve functions of immune effectors. Int J Immunopathol Pharmacol 2006; 19: 409-20.
39. Buzoni-Gatel D, Schulthess J, Menard LC, Kasper LH. Mucosal defenses against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections. Cell Microbiol 2006; 8: 535-44.
40. Ogilvie ALJ, Lüftl M, Antoni C, Schuler G, Kalden JR, Lorenz H-M. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven byTNF-alpha. Int J Immunopathol Pharmacol 2006; 19: 271-8.
41. Ferlazzo V, Sferrazza C, Caccamo N, et al. In vitro effects of aminobisphosphonate on Vγ 9Vδ 2 T cell activation an differentiation. Int J Immunopathol Pharmacol 2006; 19: 309-18.
42. Pugliese L, Bernardini I, Viola-Magni MP, Albi E. Low levels of serum cholesterol/phospholipids are associated with the antiphospholipid antibodies in monoclonal gammopathy. Int J Immunopathol Pharmacol 2006; 19: 331-8.
43. Tato CM, Villarino A, Caamano JH, Boothby M, Hunter CA. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii. J. Immunol 2003; 170: 3139-46.
44. Milláin O, Jimenez O, Fortuna V, Barceló JJ, Brunet M. Role of FK778 alone or in combination with Tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens. Int J Immunopathol Pharmacol 2006; 19: 319-30.
45. Rumio C, Besusso D, Palazzo M, et al. Degranulation of paneth cells via toll-like receptor 9. Am J Pathol 2004, 165: 373-81.
46. Maier JAM. Impact of simulated microgravity on cell cycle control and cytokine release by U937 cells. Int J Immunopathol Pharmacol 2006; 19: 279-86.
47. 8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells. Infect Immun 2005; 73: 4913-21.
48. Martinetti M, Pacati I, Cuccia M, et al. Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis virus. Int J Immunopathol Pharmacol 2006; 19: 369-78.
49. Denkers EY, Gazzinelli RT, Martin D, Sher A. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class 1-deficient mice. J Exp Med 1993, 178: 1465-72.
50. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell deficient hosts. Proc Natl Acad Sci USA 1993; 90: 6115-9.
51. 2 receptor upregulation induced by guanosine or UTP in rat brain cultured astrocytes. Int J Immunopathol Pharmacol 2006; 19: 293-308.
52. Reis e Sousa C, Sher A, Kaye P. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr Opin Immunol 1999; 11: 392-9.
53. Artavanis-Tsakonas K, Riley EM. Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol 2002, 169: 2956-63.
54. Lodoen MB, Lanier LL. Natural killer cells as an initial defense against pathogens. Current Opin Immunol 2006; 18: 391-3.
55. Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens 2001; 57: 22-31.
56. Ojo-Amaize E, Vilcek J, Cochrane A, Nussenzweig R. Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells. J Immunol 1984; 133: 1005-9.
57. D'Onofrio F, Miele L, Diaco M, et al. Sjogren's syndrome in a celiac patient: searching for environmental triggers. Int J Immunopathol Pharmacol 2006; 19: 445-8.
58. Orago A, Facer C. Cytoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythocytic schizonts: stimulation by cytokines and inhibition of neomycin. Clin Exp Immunol 1991; 86: 22-9.
59. Goteri G, Olivieri A, Ranaldi R, et al. Bone marrow histopathological and molecular changes of small B-cell lymphoma after rituximab therapy: comparison with clinical response and patient's outcome. Int J Immunopathol Pharmacol 2006; 19: 421-32.
60. Lanza A, Femiano F, De Rosa A, Cammarota M, Lanza M, Cirillo N. The N terminal fraction of desmoglein 3 encompassing its immunodominant domain is present in human serum: implications for pemphigus vulgaris autoimmunity. Int J Immunopathol Pharmacol 2006; 19: 399-408.
61. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 2003; 178: 567-77.
62. Masotti A, Mangiola A, Sabatino G, et al. Intracerebral diffusion of paramagnetic cationic liposomes containing Gd(DTPA)2- followed by MRI spectroscopy: assessment of pattern diffusion and time steadiness of a non-viral vector model. Int J Immunopathol Pharmacol 2006; 19: 379-90.
63. Maasho K, Sanchez F, Schurr E, Hailu A, Akuffo H. Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity. Infect Immun 1998, 66: 2698-704.
64. Nylen S, Maasho K, Soderstrom K, Ilg T, Akuffo H. Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon gamma. Clin Exp Immunol 2002; 131: 457-67.
65. Spadino S, Altomare A, Cainelli G, et al. Disseminated granuloma annulare: efficacy of cyclosporine therapy. Int J Immunopathol Pharmacol 2006; 19: 433-8.
66. Berberich C, Ramirez-Pineda JR, Hambrecht C, Alber G, Skeiky YA, Moll S. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecular defined antigens. J Immunol 2003; 170: 3171-9.
67. Tosoni C, Cinquini M. Diagnostic and therapeutic iter in chronic urticaria. Int J Immunopathol Pharmacol 2006; 19: 265-70.
68. Maley SW, Buxton D, Macaldowie CN, et al. Characterization of the immune response in the placenta of cattle experimentally infected with Neospora caninum in early gestation. J Comp Pathol 2006, 135: 130-41.
69. Novembre E, Calogero C, Mori F, et al. Biphasic anaphylactic reaction to Ketorolac tromethamine. Int J Immunopathol Pharmacol 2006; 19: 449-50.
70. Domizio S, Pallotta R, Romanelli A, et al. A case of Smith-Lemli-Opitz Syndrome, defect of cholesterol biosynthesis. Int J Immunopathol Pharmacol 2006; 19: 439-42.
71. Dann SM, Wang HC, Gambarin KJ, et al. Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium. J Infect Dis 2005; 192: 1294-302.
72. Mathusamy ASR, Vaidya A, Friend PJ. Clopidogrel associated acute migratory arthritis following kidney-pancreas transplantation. Int J Immunopathol Pharmacol 2006; 19: 443-4.
73. Goff WL, Storset AK, Jonson WC, Brown WC. Bovine splenic NK cells synthesize IFN- in response to IL-12-containing supernatants from Babesia bovis-exposed monocyte cultures. 2006; 28: 221-8.
74. Biassoni R, Cantoni C, Pende D, et al. Human natural killer cell receptors and co-receptors. Immunol Rev 2001; 181; 203-14.
75. Multhoff G, Botzler C, Jennen L, Schmidt J, Ellwart, Issels R. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol 1997; 158: 4341-50.
76. Gastpar R, Gehrmann M, Bausero MA et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 2005; 65: 5238-47.
77. Trapani JA, Davis J, Sutton VR, Smyth MJ. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol 2000; 12: 323-9.
78. Bradley M, Zeytun A, Rafi-Janajreh A, Nagarkatti PS, Nagarkatti M. Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells. Blood 1996; 92: 4248-55.
79. Takeda K, Hayakawa Y, Smyth MJ, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nature Med 2001; 7: 94-100.
80. Smyth MJ, Cretney E, Takeda K, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2002; 193: 661-70.
81. Hayakawa Y, Takeda K, Yagita H, et al. IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide. Blood 2002; 100: 1728-33.
82. Baxevanis CN, Dedoussis GVZ, Papadopoulos NG, et al. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor. Cancer 1995; 76: 1253-60.
83. Satarug S, Lang MA, Yongvanit P, et al. Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasitic infection, Opisthorchis viverrini. Cancer Epidemiol Biomarkers Prev 1996; 5: 795-800.
84. Ohshima H, Brouet IM, Bandaletova T, et al. Polyclonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionibacterium acnes and lipopolysaccharide. Biochem Biophys Res Commun 1992; 187: 1291-7.
85. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001-3.
86. Loilome W, Yongvanit P, Wongkham C, et al. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. Mol Carcinog 2006; 45: 279-87.
87. Abdel-Rahim AY. Parasitic infections and hepatic neoplasia. Dig Dis 2001; 19: 288-91.
88. Qiu DC, Hubbard AF, Zhong B, Zhang Y, Spear RC. A matched case-control study of the association between Schistosoma japonicum and liver and colon cancers, in rural China. Ann Trop Med Parasitol 2005; 99: 47-52
89. Sayed el-Ahl SA, el-Wakil HS, Kamel NM, Mahmoud MS. A preliminary study on the relationship of Trichomonas vaginalis and cervical cancer in Egyptian women. J Egypt Soc Parasitol 2002; 32: 167-78.
90. Zhang ZF, Begg CB. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 1994; 23: 682-90.
91. Ryan P, Hurley SF, Johnson AM, et al. Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int J Epidemiol 1993; 22: 412-9.
92. Zhang YW, Halonen SK, Ma YF, Wittner M, Weiss LM. Initial characterization of CST1, a Toxoplasma gondii cyst wall glycoprotein. Infect Immun 2001; 69: 501-7.
93. Del Brutto OH, Castillo PR, Mena IX, Freire AX. Neurocysticercosis among patients with cerebral gliomas. Arch Neurol 1997; 54: 1125-8.
94. Deepak P, Kumar S, Acharya A. Heat shock proteins (HSP): future trends in cancer immunotherapy. Eur J Inflamm 2006; 4: 1-10.
95. Olmos S, Blois S, Frecha C, Márquez G, Roux ME. Cytokines mediating inflammation in a model of secondary immunodeficiency in Wistar rats. Immunomodulation triggered by thymomodulin. Eur J Inflamm 2006; 4: 97-108.